Buy Fasoracetam | ADHD candidate | Read more:
Fasoracetam is a member of the racetam family that was designed first to treat vascular dementia and later ADHD. It is unique from other candidates that are primarily dopaminergic and acts on mGluRs. The results were positive for ADHD at 100mg+, but negative for vascular dementia. Still, mGluR mutations affect a significant portion of ADHD sufferers, making Fasoracetam a very targeted treatment. One rodent study suggests upregulation of GABAB receptors is responsible for its antidepressant effects. We hope to encourage research by allowing researchers to buy Fasoracetam.
Fasoracetam’s oral bioavailability is 79-97%, meaning it is very well absorbed.
 Fasoracetam as a treatment for ADHD: https://www.nature.com/articles/s41467-017-02244-2
 Fasoracetam’s pharmacokinetics: https://link.springer.com/article/10.2165/11319230-000000000-00000
 Fasoracetam’s actions at GABAB: https://pubmed.ncbi.nlm.nih.gov/9424016/
Scientific discussion is purely for educational purposes. This is not medical advice.